Skip to main content
Navigate Up
Sign In
 

Dr. Lieu to lead committee for investigator-initiated clinical trials

July 18, 2017


Christopher Lieu, MD
​A University of Colorado Cancer Center investigator has been recognized for leading, educating and supporting other physician/scientists. Christopher Lieu, MD, CU Cancer Center’s deputy associate director for clinical research, has received a 2017 National Cancer Institute Cancer Clinical Investigator Team Leadership Award (CCITLA).

The award is a supplement to the Cancer Center Support Grant (CCSG) recognizing CU Cancer Center as an NCI-designated comprehensive cancer center, one of 47 such centers in the United States. The supplement supports mid-level clinical investigators at NCI-designated cancer centers participating in NCI-funded clinical trials and clinical research efforts.

Lieu will lead CU Cancer Center’s efforts in further developing an Investigator-Initiated Trials Committee, which he began when he was deputy director of the CU Cancer Center’s Clinical Trials Office (CCTO). Many clinical trials are managed by drug companies hoping to test the promise of new medicines. Investigator-initiated trials allow doctors and researchers to test treatments that their hands-on experience in the lab and clinic imply may offer meaningful results. At the CU Cancer Center, the CCTO is a group of more than 100 individuals, including certified research associates, a finance team, and a regulatory team.

​​​​